Abliva AB (publ) ABLI.ST
Trading inactive
ABLI.ST
Abliva AB (publ) MVIR-B.ST
Medivir AB (publ) PROMO.ST
Promore Pharma AB (publ) KAN.ST
Kancera AB (publ) ISR.ST
ISR Immune System Regulation Holding AB (publ) COMBI.ST
CombiGene AB (publ) SCOL.ST
Scandion Oncology A/S CLINE-B.ST
Cline Scientific AB (publ) CYXO.ST
Cyxone AB (publ) AMNI.ST
Amniotics AB (publ)
Abliva AB (publ) MVIR-B.ST
Medivir AB (publ) PROMO.ST
Promore Pharma AB (publ) KAN.ST
Kancera AB (publ) ISR.ST
ISR Immune System Regulation Holding AB (publ) COMBI.ST
CombiGene AB (publ) SCOL.ST
Scandion Oncology A/S CLINE-B.ST
Cline Scientific AB (publ) CYXO.ST
Cyxone AB (publ) AMNI.ST
Amniotics AB (publ)
Performance
| Periode | ABLI.ST | MVIR-B.ST | PROMO.ST | KAN.ST | ISR.ST | COMBI.ST | SCOL.ST | CLINE-B.ST | CYXO.ST | AMNI.ST |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | 193.26 % | -24.71 % | -13.73 % | -75.81 % | -76.67 % | 2.07 % | -92.04 % | -42.50 % | -80.46 % | 42.11 % |
| YTD | 4.23 % | -25.95 % | 8.91 % | -72.45 % | 0.00 % | 8.33 % | -94.46 % | -73.46 % | 0.00 % | -34.15 % |
| 1Y | 177.50 % | -5.62 % | -86.78 % | -83.65 % | -76.78 % | -16.55 % | -97.44 % | -68.06 % | -82.03 % | -69.66 % |
| 3Y | -4.52 % | -39.77 % | -95.80 % | -87.45 % | -71.89 % | -70.73 % | -99.94 % | -98.26 % | -98.88 % | -99.96 % |
| 5Y | -44.43 % | -81.30 % | -99.05 % | -98.98 % | -86.27 % | -84.96 % | -99.99 % | -97.35 % | -99.62 % | -99.96 % |
| 10Y | -98.98 % | -89.65 % | -99.08 % | -99.25 % | -86.98 % | -98.83 % | -99.95 % | -98.85 % | -99.68 % | -99.96 % |
| From the beginning | -89.73 % | -91.07 % | -99.08 % | -99.27 % | -86.98 % | -98.58 % | -99.95 % | -98.85 % | -99.68 % | -99.96 % |